Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant CD40 anticorps (Extracellular Domain)

Cet anticorps Souris Monoclonal détecte spécifiquement CD40 dans BR. Il présente une réactivité envers Humain.
N° du produit ABIN7072684

Aperçu rapide pour Recombinant CD40 anticorps (Extracellular Domain) (ABIN7072684)

Antigène

Voir toutes CD40 Anticorps
CD40

Type d'anticorp

Recombinant Antibody

Reactivité

  • 223
  • 132
  • 26
  • 19
  • 8
  • 6
  • 6
  • 5
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
Humain

Hôte

  • 139
  • 103
  • 69
  • 8
  • 4
  • 4
  • 3
  • 2
Souris

Clonalité

  • 230
  • 93
  • 7
Monoclonal

Conjugué

  • 154
  • 30
  • 24
  • 19
  • 15
  • 7
  • 6
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp CD40 est non-conjugé

Application

  • 208
  • 100
  • 72
  • 66
  • 44
  • 34
  • 33
  • 22
  • 18
  • 16
  • 14
  • 13
  • 11
  • 8
  • 5
  • 5
  • 5
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Blocking Reagent (BR)

Clone

Chi220
  • Épitope

    • 20
    • 17
    • 17
    • 16
    • 15
    • 15
    • 14
    • 9
    • 9
    • 5
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Extracellular Domain

    Fonction

    Anti-CD40 [chi220], Mouse IgG2a, kappa

    Specificité

    This antibody binds the CD40 and blocks the humoral immune responses to T cell dependent antigens in a dose dependent manner.

    Attributs du produit

    Original Species of Ab: Mouse

    Original Format of Ab: IgG2a

    Purification

    Protein A affinity purified

    Immunogène

    This antibody was generated by immunizing female BALB/c mice with a fusion protein containing extracellular domain of human CD40 fused to the hinge CH2 and CH3 domains of a murine IgG2b antibody.

    Isotype

    IgG2a kappa
  • Indications d'application

    This antibody blocks the interaction between CD40 and gp39. Chi220 was used either alone or in combination with CTLA4-Ig in an immunosuppresive therapy study to check the survival of renal allografts in non human primate models (PMID: 12394833). Chi220 blocks binding of CD154, it also has partial agonist properties and weak stimulatory potential. It synergisticaly works with LEA29Y (belatacept) to prolong the islet allograft survival in a non-human primate Macaca fascicularis (PMID: 15611281). A study on protection of islets xenographs in diabetic macaques used a combination of Chi220 with IL-2 receptor specific antibody Basiliximab for immunosuppression with induction therapy. Chi220 is used as an sCD154 blocking agent and it was seen that it binds sCD154 in a dose dependant manner (PMID: 21920020). Two humanized versions of this antibody were generated F4 and L3.17, also showed similar properties. Humanized versions of this antibody are available on request.

    Restrictions

    For Research Use only
  • Concentration

    1 mg/mL

    Buffer

    PBS with 0.02 % Proclin 300.

    Agent conservateur

    ProClin

    Précaution d'utilisation

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C,-20 °C

    Stockage commentaire

    Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
  • Antigène

    CD40

    Autre désignation

    CD40

    Sujet

    TNFSF5, CDw40, TRAP, p50, Bp50, CD40L receptor, Tumor necrosis factor ligand superfamily member 5, B-cell surface antigen CD40, T-cell antigen Gp39, TNF-related activation protein.

    UniProt

    P29965

    Pathways

    Signalisation NF-kappaB, Cellular Response to Molecule of Bacterial Origin, M Phase, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints
Vous êtes ici:
Chat with us!